Lidorestat (IDD 676) for the Treatment of Diabetic Neuropathy
1 other identifier
interventional
N/A
2 countries
14
Brief Summary
This clinical trial is to determine an effective dosage and to study the safety of an investigational drug -lidorestat (IDD-676)- which is intended to stop or slow the progression of diabetic peripheral neuropathy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
14 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 13, 2002
CompletedFirst Posted
Study publicly available on registry
August 15, 2002
CompletedJune 24, 2005
December 1, 2002
August 13, 2002
June 23, 2005
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of Type 1 or Type II diabetes with mild to moderate diabetic peripheral neuropathy.
- Healthy status except for diabetes
- Ability to make frequent clinic visits over a 7-month period.
- Willingness and ability to understand and sign consent form.
You may not qualify if:
- Pregnancy or breast feeding
- Presence of uncontrolled hypertension
- History or presence of significant kidney or liver disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (14)
Scottsdale Medical Specialists
Scottsdale, Arizona, United States
Glendale Adventist Medical Center
Glendale, California, 91206, United States
Marin Endocrinology Associates
Greenbrae, California, United States
Diabetes & Endocrine Associates
La Jolla, California, 92037, United States
Radiant Research
Gainesville, Florida, 32605, United States
University of Miami, Dept. of Diabetes, Endocrinology & Metabolism
Miami, Florida, 33136, United States
Johns Hopkins University - School of Medicine
Baltimore, Maryland, 21205, United States
Brody School of Medicine, East Carolina University
Greenville, North Carolina, United States
University of Oklahoma
Oklahoma City, Oklahoma, United States
University of Texas, Southwest Medical Center
Dallas, Texas, United States
Diabetes & Glandular Disease Clinic
San Antonio, Texas, United States
Toronto General Hospital, University Health Network
Toronto, Ontario, Canada
Centre de Recherche
Laval, Quebec, Canada
Hospital de L'Enfant-Jesus
Québec, Quebec, Canada